Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$102.42 -0.76 | -0.74%
01/23/17 - 02:06 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 71.91M 64.54M 48.97M 31.39M
Cost of Sales 5.81M 2.79M 3.07M 382.00K
Gross Operating Profit 66.11M 61.75M 45.90M 31.01M
Selling, General, and Administrative Expenses 25.40M 23.65M 18.54M 15.78M
Research & Development 13.38M 12.12M 9.27M 10.79M
Operating Income before D & A (EBITDA) 27.33M 25.98M 18.09M 4.43M
Depreciation & Amortization 12.90M 6.35M 2.66M 3.22M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 24.95M -3.46M -3.66M -2.16M
Special Income / Charges 0.00 0.00 -480.00K 0.00
Total Income Before Interest Expenses (EBIT) 34.23M 16.16M 11.28M -941.00K
Interest Expense 11.80M 4.86M 2.08M 2.92M
Pre-Tax Income 22.43M 11.30M 9.21M -3.87M
Income Taxes -192.12M 410.00K 374.00K -1.19M
Minority Interest -2.38M -1.13M 0.00 0.00
Net Income From Continuing Operations 227.44M 10.89M 8.83M -2.67M
Net Income From Discontinued Operations 0.00 0.00 2.59M 2.15M
Net Income From Total Operations 227.44M 10.89M 11.42M -527.00K
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 229.82M 12.02M 11.42M -527.00K
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
227.44M 10.89M 9.31M -2.67M
Preferred Dividends
Net Income Available To Common 227.44M 10.89M 8.83M -2.67M
Basic EPS from Continuing Ops. 11.61 0.59 0.43 -0.14
Basic EPS from Discontinued Ops. 0.00 0.00 0.13 0.11
Basic EPS from Total Operations 11.61 0.59 0.56 -0.03
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 11.61 0.59 0.56 -0.03
Basic Normalized Net Income/Share 11.61 0.59 0.45 -0.14
EPS fr Continuing Ops. 10.83 0.56 0.43 -0.14
EPS fr Discontinued Ops 0.00 0.00 0.12 0.11
EPS fr Total Ops. 10.83 0.56 0.55 -0.03
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 10.83 0.56 0.55 -0.03
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
10.83 0.56 0.45 -0.14
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter